Chang Christopher Y, Chabot Peter, Thomas James P
Fauquier Ear, Nose, and Throat Consultants, PLC, Warrenton, VA 20186, USA.
Otolaryngol Head Neck Surg. 2007 Jun;136(6):894-9. doi: 10.1016/j.otohns.2007.01.035.
Objective evaluation of botulinum toxin A (BTX-A) dosing by determination of the statistical relationship between injection amount and duration of side effects and normal voice in adductor spasmodic dysphonia (SD) patients. From this information, to provide a rational guide to determine the initial and follow-up BTX-A amounts for injection.
Private laryngology clinic. Statistical analysis was performed on data obtained from 101 patients with SD.
Significant and predictable positive correlations were found between duration of side effects and duration of normal voice after BTX-A injection in patients with SD. Dose of BTX-A injected also appeared to have a significant positive correlation with duration of side effects, but a negative correlation with duration of normal voice. A trend toward more severe side effects was seen with larger doses of BTX-A injections.
Increased understanding of the response of the human voice over time after BTX-A injection at various doses suggests new ideas to further increase clinical efficacy with the use of lower BTX-A doses.
通过确定肉毒杆菌毒素A(BTX-A)注射量与内收型痉挛性发声障碍(SD)患者副作用持续时间及正常嗓音持续时间之间的统计关系,对BTX-A剂量进行客观评估。基于这些信息,为确定BTX-A注射的初始剂量和后续剂量提供合理指导。
私立喉科诊所。对101例SD患者的数据进行统计分析。
在SD患者中,BTX-A注射后副作用持续时间与正常嗓音持续时间之间存在显著且可预测的正相关。注射的BTX-A剂量似乎也与副作用持续时间呈显著正相关,但与正常嗓音持续时间呈负相关。BTX-A注射剂量越大,副作用越严重的趋势越明显。
对不同剂量BTX-A注射后人体嗓音随时间变化反应的进一步了解,为使用更低剂量BTX-A进一步提高临床疗效提供了新思路。